SafeTrace Tx(R) Selected by Prestigious New York City University Hospital DENVER, Aug. 5 /PRNewswire-FirstCall/ -- NewYork-Presbyterian Hospital, one of the most prestigious medical centers in the world, has purchased SafeTrace Tx(R)* from Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"). The advanced transfusion management system will be used at its NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Allen Pavilion sites. Terms of the agreement were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Henri Thomas, Manager, AIS for NewYork-Presbyterian Hospital/Columbia University Medical Center, stated, "Wyndgate has successfully developed software to manage the complexities of our transfusion service business. We selected SafeTrace Tx for its comprehensive safety features and application capabilities, which will facilitate our vision of NewYork-Presbyterian's future." Mr. Thomas continued, "Other factors influencing our decision to purchase SafeTrace Tx were Wyndgate's market experience, reputation, application functionality, product lifecycle, implementation experience, product support and commitment to our future." Thomas F. Marcinek, President and COO of Global Med Technologies, Inc., stated, "We are delighted that NewYork-Presbyterian Hospital now joins the migration of many leading health care institutions to our products and services. Wyndgate supports NewYork-Presbyterian's purchase with our quality staff, reputation for service, commitment to excellence and high technological standards that are known to the industry." Mr. Marcinek added, "We believe this significant business agreement with NewYork-Presbyterian Hospital underscores our commitment to quality and safety in helping health care facilities of all sizes and levels of complexity efficiently manage transfusion operations." About NewYork-Presbyterian Hospital NewYork-Presbyterian Hospital -- based in New York City -- is the largest not-for-profit, non-sectarian hospital in the country, with 2,397 beds. It provides state-of-the-art inpatient, ambulatory, and preventive care in all areas of medicine at five major centers: NewYork-Presbyterian Hospital/Weill Cornell Medical Center, NewYork-Presbyterian Hospital/Columbia University Medical Center, Morgan Stanley Children's Hospital of NewYork-Presbyterian, NewYork-Presbyterian Hospital/Allen Pavilion, and NewYork-Presbyterian Hospital/Westchester Division. One of the largest and most comprehensive health-care institutions in the world, the Hospital is committed to excellence in patient care, research, education, and community service. It consistently ranks as one of the top hospitals in the country in U.S. News & World Report's guide to "America's Best Hospitals, in New York magazine's Best Doctors issue, in Solucient's top 15 major teaching hospitals, and in many other leading surveys. The Hospital has academic affiliations with two of the country's leading medical colleges: Joan and Sanford I. Weill Medical College of Cornell University, and Columbia University College of Physicians & Surgeons. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R), Inc., +1-303-238-2000; or Investor Relations, John Nesbett, or Jordan Silverstein both of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies, Inc. Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/

Copyright